newsfilter
← Latest News
ACCESS Newswire·

Altamira Therapeutics Announces IND Clearance by U.S. FDA for AM-125 in Acute Vestibular Syndrome

HAMILTON, BERMUDA / ACCESSWIRE / June 15, 2023 / Altamira Therapeutics Ltd. , a company dedicated to developing therapeutics that address important unmet